Pure Global AI
NCT06419816Not yet recruiting

Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus

A Primary Care-Based, Prospective, Multicenter, Cluster-Randomized, Pragmatic Clinical Trials to Determine the Effect of Linking Data With Investigators When Using the Electronic Health Record-Linked Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
Daewoong Pharmaceutical Co. LTD.ClinicalTrials.govother
Verified
Study focus
Disease/Condition
Type 2 Diabetes
Drug/Device/Intervention
Physician-managed WellCheck use
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Daewoong Pharmaceutical Co. LTD.
Timeline & enrollment
Phase
N/A
Start date
Jun 30, 2024
End date
Jun 30, 2026
Enrollment
480 participants
Primary outcome

change in glycated hemoglobin (HbA1c) levels

Summary

This clinical study aims to evaluate the effects of using the WellCheck mobile application
 on blood glucose, blood pressure, and weight among Type 2 diabetes patients in real primary
 care settings. It is a prospective, multi-center, cluster-randomized, pragmatic clinical
 trial. Patients who can use the digital healthcare mobile application without difficulty are
 recruited based on the clinical judgment of the attending physician.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06419816
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06419816 through Pure Global AI's free database. This phase not specified trial is sponsored by Daewoong Pharmaceutical Co. LTD. and is currently Not yet recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 480 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.